Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
674
datasets available to search
ShareScore release 0.9.0
Dataset results
674 results for “Multicentric”
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland – a multicentre cohort study
<p>For details, see publication</p>
Mouse_rest_multicentre
Open the record for dataset details and reuse information.
European Study on Risk Factors for Violence in Mental Disorder and Forensic Care: a multicentre project. The EU-Viormed Dataset
<p>The aims of this project, through a series of interlinked work packages, designed by researchers and practicing clinicians, and lead by an experienced management team, is to explore and map these differences, test new risk assessment tools and identify and share best practice where it exists. It aims are fourfold. Firstly to describe forensic psychiatry services as they exist today in 2017 across the European Union. Secondly to identify risk factors for violence in a unique international forensic sample and thirdly to test for the very first time in a related EU sample two contrasting methods of violence risk assessment. Finally it explored what works for these often marginalised patients, their families and their carers, at an operational, clinical and ethical level.<br> These aims were achieved through two studies designs:<br> Study 1: case-control retrospective design in which forensic patients with Schizophrenia<br> Spectrum Disorders (SSDs) who have a history of interpersonal violence and live in forensic<br> units will be compared to non-violent patients with SSDs living in the community.<br> Study 2: prospective cohort study, with 6 and 12 month follow-up, to test the predictive validity<br> of the leading structured professional clinical judgement guide for violence prediction, the<br> HCR-20v3, the Forensic Psychiatry and Violence Tool (FoVOx) and the Mental Illness and<br> Suicide Tool (OXMIS, https://oxrisk.com/)</p>
Fibrinogen depletion coagulopathy predicts major bleeding after thrombolysis for ischemic stroke: a multicentre study
<p>Dataset from "Fibrinogen depletion coagulopathy predicts major bleeding after thrombolysis for ischemic stroke: a multicentre study", Romoli & Vandelli et al., Stroke 2022</p>
Dataset related to article "Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke"
<p>https://figshare.com/search?q=10.6084%2Fm9.figshare.21346731</p>
Assessment of Self-Medication Practices and Safety Profile of Medicines Utilisation among Pregnant Women attending Antenatal Clinics in Freetown, Sierra Leone: A Multicentre Cross-Sectional Descriptive Study
<p><strong><span>Background: </span></strong><span>Despite the potential fetal and maternal risks of self-medication, studies on self-medication practice and the safety profile of medicines used during pregnancy are scarce in our setting. This study determined the self-medication practice and safety profile of medicines used among pregnant women.</span></p> <p><strong><span>Methods: </span></strong><span>This cross-sectional study was conducted in face-to-face interviews among 345 pregnant women at three hospitals in Sierra Leone. Data were analyzed using descriptive statistics and binary logistic regression to <span>determine the prevalence and associated factors of self-medication. </span></span></p> <p><strong><span>Results: </span></strong><span>A total of 345 pregnant women participated in the study. The prevalence of self-medication among pregnant women with conventional and/or herbal medicine was </span><span>132 (38.3%)</span><span>. Also, 93 (75%) of the conventional medicines (CMs) were categorized as probably safe, of which paracetamol 36 (29.0%) was commonly used, followed by amoxicillin 23 (18.5%) and antimalarials 22 (17.7%) for common illnesses such as </span><span>headache 30 (25.4%), </span><span>urinary tract infection </span><span>23 (19.4%)<span> and malaria 22 (18.6%). The common reason for self-medication was previous experience with the disease 24 (27.3%). </span><em>Luffa acutangula</em> 19 (30.2%) <span>was the most used herbal medicine (HM), </span>and Oedema 30 (47.6%) was the most reported ailment. <span>Among the HM users,</span> 34 (54.0%)<span> believe they are more effective than CMs. Secondary school education (AOR = 2.128, 95%CI = 1.191 – 3.804, p = 0.011), tertiary education (AOR = 2.915, 95%CI = 1.104 – 7.693, p = 0.031), monthly income of greater than NLe 1,000 (AOR = 4.084, 95% CI = 1.269 – 13.144, p = 0.018), and perceived maternal illness (AOR = 0.367, CI = 0.213 – 0.632, p = <0.001) were predictors of self-medication.</span></span></p> <p><strong><span>Conclusion: </span></strong><span>Self-medication practice was highly prevalent and was associated with educational status, monthly income, and maternal illness during pregnancy. Therefore, intervention programs should be designed and implemented to minimize the practice and risk associated with self-medication among pregnant women.</span></p>
: Enzobiotics –A Novel Therapy For Elimination Of Uremic Toxins In Ckd Patients (EETOX Study)–Multicentric Double-Blinded Randomised Controlled Trial
<p>Supplementary file for <strong>: </strong><strong>Enzobiotics –A Novel Therapy For </strong><strong>Elimination Of Uremic Toxins In Ckd Patients (EETOX Study)–Multicentric Double-Blinded Randomised Controlled Trial</strong></p>
Mass spectrometry- based biomarkers to detect prostate cancer: A multicentric study based on non- invasive urine collection without prior intervention
<p>These are datasets related to mass spectrometry proteomics analysis, in particular Capillary Electrophoresis coupled to Mass Spectrometery (CE-MS). CE-MS was employed to acquire proteomics profiles from 970 patients from two different clinical centers. with the aim to develop a biomarker model to detect Prostate Cancer. </p>
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00287118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
ClinicalTrials.gov study NCT01024036. IPD Sharing: Not stated. Countries: 23. Publications: 3.
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times
ClinicalTrials.gov study NCT01198132. IPD Sharing: Not stated. Countries: 1. Publications: 1.
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study
ClinicalTrials.gov study NCT02817828. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes
ClinicalTrials.gov study NCT02814838. IPD Sharing: NO. Countries: 3. Publications: 1.
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
ClinicalTrials.gov study NCT02441218. IPD Sharing: YES. Countries: 2. Publications: 4.
Multicentric RCT Comparing High Purity Type I Collagen-Skin Substitute vs dHACM in Treatment of Diabetic Foot Ulcers
ClinicalTrials.gov study NCT07046403. IPD Sharing: NO. Countries: 1. Publications: 8.
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
ClinicalTrials.gov study NCT03933904. IPD Sharing: NO. Countries: 1. Publications: 3.
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
ClinicalTrials.gov study NCT03402841. IPD Sharing: YES. Countries: 19. Publications: 11.
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study
ClinicalTrials.gov study NCT02817841. IPD Sharing: NO. Countries: 2. Publications: 1.
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
ClinicalTrials.gov study NCT06625203. IPD Sharing: YES. Countries: 4. Publications: 7.
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
ClinicalTrials.gov study NCT00418574. IPD Sharing: Not stated. Countries: 9. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.